A detailed history of Legal & General Group PLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 334,882 shares of CPRX stock, worth $7.15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
334,882
Previous 334,882 -0.0%
Holding current value
$7.15 Million
Previous $6.66 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$15.19 - $21.35 $319,020 - $448,392
21,002 Added 6.69%
334,882 $6.66 Million
Q2 2024

Aug 14, 2024

BUY
$14.68 - $16.92 $64,430 - $74,261
4,389 Added 1.42%
313,880 $4.86 Million
Q1 2024

May 14, 2024

BUY
$13.18 - $17.11 $285,689 - $370,876
21,676 Added 7.53%
309,491 $4.93 Million
Q4 2023

Feb 15, 2024

SELL
$11.78 - $17.29 $5,242 - $7,694
-445 Reduced 0.15%
287,815 $4.84 Million
Q3 2023

Nov 14, 2023

BUY
$11.69 - $15.02 $82,905 - $106,521
7,092 Added 2.52%
288,260 $3.37 Million
Q2 2023

Aug 14, 2023

BUY
$11.5 - $18.08 $478,170 - $751,766
41,580 Added 17.35%
281,168 $3.78 Million
Q1 2023

May 15, 2023

SELL
$14.34 - $21.05 $5,520 - $8,104
-385 Reduced 0.16%
239,588 $3.97 Million
Q4 2022

Feb 14, 2023

BUY
$12.25 - $19.5 $164,738 - $262,236
13,448 Added 5.94%
239,973 $4.46 Million
Q3 2022

Nov 14, 2022

BUY
$7.06 - $15.52 $1.33 Million - $2.93 Million
188,774 Added 500.05%
226,525 $2.91 Million
Q2 2022

Aug 22, 2022

BUY
$6.23 - $8.57 $18,172 - $24,998
2,917 Added 8.37%
37,751 $265,000
Q3 2021

Nov 15, 2021

BUY
$4.85 - $6.04 $94,541 - $117,737
19,493 Added 127.06%
34,834 $185,000
Q2 2021

Aug 12, 2021

SELL
$4.29 - $6.05 $39,824 - $56,162
-9,283 Reduced 37.7%
15,341 $88,000
Q1 2021

May 17, 2021

BUY
$3.45 - $4.69 $37,456 - $50,919
10,857 Added 78.86%
24,624 $114,000
Q3 2020

Nov 13, 2020

SELL
$2.97 - $5.08 $12,738 - $21,788
-4,289 Reduced 23.75%
13,767 $41,000
Q2 2020

Aug 14, 2020

BUY
$3.48 - $5.05 $2,902 - $4,211
834 Added 4.84%
18,056 $84,000
Q1 2020

May 14, 2020

SELL
$2.61 - $5.21 $11,314 - $22,585
-4,335 Reduced 20.11%
17,222 $66,000
Q4 2019

Feb 13, 2020

SELL
$3.67 - $5.7 $5,031 - $7,814
-1,371 Reduced 5.98%
21,557 $81,000
Q3 2019

Nov 13, 2019

SELL
$3.89 - $7.43 $4,901 - $9,361
-1,260 Reduced 5.21%
22,928 $121,000
Q2 2019

Aug 14, 2019

BUY
$2.7 - $6.11 $25,515 - $57,739
9,450 Added 64.12%
24,188 $93,000
Q2 2018

Aug 10, 2018

SELL
$2.26 - $3.84 $1,550 - $2,634
-686 Reduced 4.45%
14,738 $46,000
Q1 2018

May 17, 2018

SELL
$2.39 - $4.01 $3,931 - $6,596
-1,645 Reduced 9.64%
15,424 $37,000
Q4 2017

Feb 13, 2018

BUY
$2.51 - $4.4 $42,843 - $75,103
17,069
17,069 $68,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.2B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.